Success Stories: NIW Petition for Biomedical Scientist Approved with NAILG’s Expert Legal Strategy

Client’s Testimonial:

“Congratulations to us for the I-140 approval. Thank you so much for your help with this. I really appreciate your support and for working with me on this.”

On May 9^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Fellow in the Field of Biomedical Sciences (Approval Notice).

General Field: Biomedical Sciences

Position at the Time of Case Filing: Research Fellow

Country of Origin: Estonia

State of Residence at the Time of Filing: Maryland

Approval Notice Date: May 9^th, 2025

Processing Time: 1 month, 6 days (Premium Processing Requested)

Case Summary:

Our client, a distinguished biomedical scientist, sought the North America Immigration Law Group (NAILG) to assist with her National Interest Waiver (NIW) petition. Specializing in antiviral therapeutics, she focuses on developing and characterizing preventive and therapeutic agents by leveraging advanced molecular virology, multi-omics, and immune profiling techniques. Her research aims to unravel complex virus-host interactions, which are essential for improving existing virus mitigation strategies and for pioneering novel approaches to treat viral infections. This work is of undeniable national importance, particularly given the ongoing global emphasis on strengthening pandemic preparedness and public health resilience in the United States.

Throughout her career, she has established a significant academic footprint. Her research has been published in 23 peer-reviewed journal articles and 1 preprint, appearing in no fewer than 13 highly ranked scientific journals. The global reach and influence of her work are underscored by 854 citations to date, a testament to its vital contribution to the biomedical sciences community. Her findings have advanced the understanding of viral behavior and informed the development of more effective antiviral agents, directly supporting efforts to reduce the impact of infectious diseases on public health.

Upon engaging with NAILG, our team took a hands-on approach to crafting a robust NIW petition that communicated the critical nature and far-reaching implications of her work. We emphasized not only her technical expertise but also the tangible benefits her research offers to U.S. healthcare priorities. By strategically highlighting how her innovative approaches to studying virus-host dynamics align with national goals, we made a compelling case for her continued contributions to biomedical research on a national scale.

Our efforts included thorough documentation of her scholarly achievements, careful framing of the petition’s narrative to underscore societal impact, and meticulous preparation to ensure clarity and coherence for immigration officials. NAILG’s expertise was essential in translating complex scientific research into accessible, persuasive arguments that met the rigorous standards required for NIW approval.

We deeply appreciate our client’s trust in NAILG to guide her through this intricate process. Securing her NIW approval not only acknowledges her exceptional scientific contributions but also enables her to continue advancing crucial antiviral research that strengthens U.S. capabilities in infectious disease prevention and treatment. We look forward to supporting her ongoing efforts to improve public health outcomes both nationally and globally.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.